Peptide Therapeutics Market to Witness 5.94% CAGR by 2031 | SkyQuest Technology
27 sept. 2024 08h00 HE
|
SkyQuest Technology Consulting Pvt. Ltd.
Westford, USA, Sept. 27, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that Peptide Therapeutics Market will attain the value of USD 68.4 Billion by 2031, with a CAGR of 5.94% during the forecast...
Zealand Pharma conference call on August 15 at 2pm CET (8am ET) to present first half 2024 financial results
12 août 2024 11h00 HE
|
Zealand Pharma
Press Release – No. 8 / 2024 Zealand Pharma conference call on August 15 at 2pm CET (8am ET) to present first half 2024 financial results Copenhagen, Denmark, August 12,...
Global Peptide Therapeutics Market to Grow Significantly at a CAGR of ~10% by 2030| DelveInsight
17 juil. 2024 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, July 17, 2024 (GLOBE NEWSWIRE) -- Global Peptide Therapeutics Market to Grow Significantly at a CAGR of ~10% by 2030| DelveInsight The increasing prevalence of conditions like...
Zealand Pharma announces topline results from the mechanistic investigator-led DREAM trial with low doses of GLP-1/GLP-2 receptor dual agonist dapiglutide
23 mai 2024 14h45 HE
|
Zealand Pharma
Company announcement – No. 27 / 2024 Zealand Pharma announces topline results from the mechanistic investigator-led DREAM trial with low doses of GLP-1/GLP-2 receptor dual agonist dapiglutide Mean...
Zealand Pharma Announces Financial Results for the Full Year 2023
27 févr. 2024 01h00 HE
|
Zealand Pharma
Company announcement - No. 9 / 2024 Zealand Pharma Announces Financial Results for the Full Year 2023 Significant progress delivered across our obesity and rare disease assets while building a...
Peptide Therapeutics Market Size Worth USD 75.92 Billion in 2032 | Emergen Research
17 janv. 2024 12h58 HE
|
Emergen Research
Vancouver, Jan. 17, 2024 (GLOBE NEWSWIRE) -- The global peptide therapeutics market size was USD 42.70 Billion in 2022 and is expected to register a revenue CAGR of 6.0% during the forecast period....
Zealand Pharma to participate in the Goldman Sachs Healthcare C-Suite Unscripted Conference on January 4th
02 janv. 2024 02h00 HE
|
Zealand Pharma
Press Release – No. 1 / 2024 Zealand Pharma to participate in the Goldman Sachs Healthcare C-Suite Unscripted Conference on January 4th Copenhagen, Denmark, January 2, 2024 – Zealand...
Zealand Pharma presents data for amylin analog ZP8396 at ObesityWeek
17 oct. 2023 02h00 HE
|
Zealand Pharma
Press release – No. 13 / 2023 Zealand Pharma presents data for amylin analog ZP8396 at ObesityWeek Copenhagen, Denmark, October 17, 2023 – Zealand Pharma A/S (Nasdaq: ZEAL) (“Zealand”) (CVR-no....
[Size Report] Peptide Therapeutics Market (9.2% CAGR by 2027) to Hit $50 Billion, Globally, with Hybrid Technology Segment Driving Growth During 2020-2027 | The Insight Partners
12 juil. 2023 08h53 HE
|
The Insight Partners
Pune, India, July 12, 2023 (GLOBE NEWSWIRE) -- According to Recently Published Report by The Insight Partners, “Peptide Therapeutics Market Size Report and Forecast to 2027 - COVID-19 Impact and...
Zealand Pharma announces positive results from Part 1 of multiple ascending dose trial with amylin analog ZP8396
03 juil. 2023 06h01 HE
|
Zealand Pharma
Company announcement – No. 27 / 2023 Zealand Pharma announces positive results from Part 1 of multiple ascending dose trial with amylin analog ZP8396 Doses of 0.6 and 1.2 mg ZP8396...